A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy
- PMID: 21397314
- DOI: 10.1016/j.jaci.2011.01.051
A phase II, randomized, double‑blind, parallel‑group, placebo‑controlled oral food challenge trial of Xolair (omalizumab) in peanut allergy
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
